Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase EARLY_PHASE1 2Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Omacor × Clear all
NCT01823991 2020-07-14

COGNUTRIN in Breast Cancer Survivors

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
36 enrolled 15 charts
Breast

Breast Neoplasms

NCT01784042 2017-05-09

Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue

Milton S. Hershey Medical Center

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡